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46 The Journal of Thoracic and Cardiobjective: Management options for pleural space infections have changed over the
ast 2 decades. This study evaluated trends over time in the incidence of disease and
se of different management strategies and their associated outcomes.
ethods: A retrospective study was performed by using a statewide administrative
atabase of all hospitalizations for pleural space infections between 1987 and 2004.
esults: Four thousand four hundred twenty-four patients (age, 57.1  18.6 years;
7% male; comorbidity index, 1.1  1.9) were hospitalized with pleural space
nfections. The incidence rate increased 2.8% per year (95% confidence interval,
.2%-3.4%; P  .001). Overall, 51.6% of patients underwent an operation, and the
roportion increased from 42.4% in 1987 to 58.4% in 2004 (P  .001). The risk of
eath within 30 days was less for patients undergoing operations compared with that
or patients not undergoing operations (5.4% vs 16.6%, P  .001); however,
atients undergoing operations were younger (52.9  17.6 years vs 61.5  18.6
ears, P  .001) and had a lower comorbidity index (0.8  1.6 vs 1.4  2.1, P 
001). After adjusting for age, sex, comorbidity index, and insurance status, patients
ndergoing operative therapy had a 58% lower risk of death (odds ratio, 0.42; 95%
onfidence interval, 0.32-0.56; P  .001) than those undergoing nonoperative
anagement.
onclusions: The incidence of pleural space infections and the proportion of
atients undergoing operative management have increased over time. Patients
ndergoing operations were younger and had less comorbid illness than those not
ndergoing operations but had a much lower risk of early death, even after adjusting
or these factors.
leural space infections are associated with considerable morbidity, mortality,
and health care resource use.1-4 Although drainage of the pleural space 
key component of care, the extent of drainage and debridement has long been
ebated.5 Options include nonoperative (thoracentesis and tube thoracostomy) 
perative (thoracotomy with decortication) intervention. Recent additions to these 2
anagement approaches include image-guided catheters and operations performed
y using video-assisted thoracoscopic surgery (VATS), respectively.
A meta-analysis of largely retrospective cohort studies and historically controlled
ase series revealed lower early mortality (2%-5% vs 9%-10%) and reintervention
0%-11% vs 40%-46%) rates for primary operative versus nonoperative drain1
owever, different patient characteristics among the different treatment groups
ight have influenced these outcomes. Only one randomized trial addressed this
ssue, comparing operative (primary VATS) with nonoperative (primary tube tho-
acostomy and fibrinolytic therapy) therapy, with the findings that patients under-
oing VATS experienced significantly fewer treatment failures and hospital and
hest tube days.6 Unfortunately, an insufficient number of patients (n  20) was
vascular Surgery ● February 2007
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TSnrolled to meaningfully evaluate whether early VATS ac-
ually decreased the risk of death. Because of these limita-
ions, the approach to pleural space infection varies between
hysicians. Practice patterns are likely influenced by spe-
ialization, access to thoracic surgeons, and conventional
isdom and training.
It is unclear how the growing availability of new man-
gement options for pleural drainage has affected clinical
ractice in the community at large. The management of
leural space infections has never been described at the
opulation level. We examined trends in the incidence of
isease and operative management over an 18-year period
n the state of Washington, and evaluated differences in
aseline characteristics and outcomes between patients un-
ergoing operations and those not undergoing operations.
aterials and Methods
tudy Design
retrospective cohort study was performed by using a statewide
ospital discharge database. This study was exempted from human
ubject review by agreement of the University of Washington
ubject Review Committee and the Washington State Department
f Health. The data set contains no direct identifiers and is con-
idered within the public domain.
etting and Data Source
he Washington State Comprehensive Hospital Abstract Report-
ng System database contains records of all hospitalizations occur-
ing between 1987 and 2004, except those at Veterans Affairs and
S military hospitals. This data set includes demographic infor-
ation (age and sex); International Classification of Diseases,
inth Revision (ICD-9) diagnostic and procedure codes; adminis-
rative details of hospitalization (insurance status, length of stay,
harges, and disposition); and coded hospital identifiers. Thirty-
ay mortality was determined by means of linkage of the Com-
rehensive Hospital Abstract Reporting System to the Washington
tate Department of Health vital records database. Estimates of the
tatewide population were derived from the US Census Bureau.
atients and Definitions
ases were defined as all patients hospitalized between 1987 and
004 with a pleural space infection (ICD-9 diagnostic codes for
ither empyema with or without fistula [510.0, 510.9] or infected
leural effusion [511.1]) whose hospitalization also included a
leural drainage procedure (ICD-9 procedure codes for operative
Abbreviations and Acronyms
CI  confidence interval
ICD-9  International Classification of Diseases,
Ninth Revision
ICF  institutional care facility
VATS video-assisted thoracoscopic surgeryrainage of the pleural space [34.0, 34.01, 34.02, 34.09, 34.21], c
The Journal of Thoracicecortication [34.51, 34.59], closure of a bronchopleural fistula
33.42, 34.73], thoracentesis [34.91], or tube thoracostomy
34.04]). Patients less than 18 years of age were excluded. ICD-9
iagnostic codes for the cause or chronicity of infection do not
xist, and thus categorization by cause, chronicity, or both was not
ossible. Categorization by the presence or absence of a fistula was
ot attempted because ICD-9 diagnostic codes are unlikely to
eliably identify that level of clinical detail. Patients with proce-
ure codes (see Appendix E1) for thoracic operations performed
or conditions other than pleural space infection were also ex-
luded. The latter were believed to more likely represent patients
ho had pleural space infection as a complication of their thoracic
perations. Operative therapy was defined by procedure codes for
perative drainage of the pleural space, decortication, or closure of a
ronchopleural fistula. Nonoperative therapy was defined by proce-
ure codes for thoracentesis or tube thoracostomy. Because ICD-9
rocedure codes do not capture the timing or number of interven-
ions and because the reliability of these codes for procedures that
ccur at the bedside, as opposed to the operating room, is un-
nown, we did not analyze subcategories of operative and nonop-
rative therapy.
utcomes
utcomes of interest included 30-day mortality, readmission
ithin 30 days of discharge for a diagnosis of pleural space
nfection, discharge to an institutional care facility (ICF), length of
tay, and costs. Discharge to an ICF was a dichotomized variable
ndicating whether a patient went to another facility, such as a
killed nursing, intermediate-care, or rehabilitation facility, versus
ome. Calculation of the proportion discharged to an ICF excluded
atients who died in the hospital. Costs were calculated from
ospital charges using the Medicare charge-to-cost ratio for Wash-
ngton State7 and adjusted for inflation by using the Consu
rice Index for Medical Care.8
ovariates
he Deyo modification of the Charlson comorbidity index (0-3)
as calculated by using ICD-9 diagnostic codes from index ad-
issions.9 A value of zero indicates no comorbid conditi
hereas an index of 3 or greater indicates the greatest extent of
omorbidity. Insurance status was considered a marker for eco-
omic status and was a dichotomized variable indicating whether
he primary payer was Medicaid or the case was considered
charity” versus all other types of payers, such as Medicare, a
ealth maintenance organization, Blue Cross/Blue Shield, or com-
ercial insurance.
nalysis
oisson regression was used to test for a change in the incidence
f pleural space infection over the time of the study by using age-
nd sex-standardized data. Data were directly standardized for age
nd sex by using year 2000 population data as a reference. Trends
n patient characteristics, management, and outcomes were re-
orted across three 6-year time categories. Tests for trends over
ime were based on linear (for continuous variables) and logistic
egression (for categoric variables) analyses by using yearly time
ategories as the independent variable.
and Cardiovascular Surgery ● Volume 133, Number 2 347
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G
TSFor comparisons of outcomes between patients treated opera-
ively and nonoperatively, 2 tests were used for categoric vari-
bles, and the unpaired t test was used for continuous variables.
ogistic regression was used to examine the association between
eceipt of operative therapy and death within 30 days of discharge,
eadmission, and discharge to an ICF. The cumulative patient
atality rate was estimated for the entire cohort and operative and
onoperative groups by using the Kaplan–Meier method. A log-
ank test was used to test for an unadjusted difference in patient
atality rate between the 2 groups. Cox regression was used to
rovide adjusted estimates of the instantaneous hazard of death.
egression models were built to first include unadjusted variables
nd then added patient age, sex, comorbidity index, and insurance
tatus as confounding variables. Adjustments for clustering at the
ospital level were performed to account for similarities among
atients treated in the same hospital. Statistical analyses were
erformed by using STATA version 9 (STATA Corp, College
tation, Tex).
igure 1. Age- and sex-adjusted incidence of pleural space in-
ection in Washington State from 1987 through 2004.
ABLE 1. Temporal trends in patient characteristics, mana
All (n  4424) 1
haracteristics
Age (y, mean  SD) 57.1  18.6
Male sex (%) 66.8
Comorbidity index (mean  SD) 1.1  1.9
Medicaid/charity (%) 16.7
anagement
Operative (%) 51.6
utcomes
30-d Mortality (%) 10.8
Readmission (%) 4.4
Discharge to ICF (%) 26.0
LOS (d, mean  SD) 14.1  11.8
Costs ($, mean  SD) 27,368  34,578D, Standard deviation; ICF, institutional care facility; LOS, length of stay.
48 The Journal of Thoracic and Cardiovascular Surgery ● Febresults
our thousand four hundred twenty-four patients (mean 
tandard deviation age, 57.1  18.6 years; 66.8% men)
ere hospitalized with pleural space infection and under-
ent some form of drainage procedure in Washington State
etween 1987 and 2004. A large percentage of patients
16.7%) was considered to have low socioeconomic status
ased on the payer source described as either Medicaid or
harity care. The age- and sex-adjusted incidence of pleural
pace infection increased 2.8% per year (95% confidence
nterval [CI], 2.2%-3.4%; P  .001), with a peak of 7.6
ases per 100,000 state residents in 2004 (Figure 1).
Table 1 demonstrates differences in patient characte
ics, operative management, and outcomes averaged across
-year time periods. Mean age and sex distribution did not
hange over the study period (P  .64 and P  .54,
espectively), although the mean comorbidity index and
roportion of patients with Medicaid/charity care increased
P  .01 and P  .01, respectively). Overall, 51.6% of
atients underwent an operation, and the proportion in-
reased from 42.4% in 1987 to 58.4% in 2004 (P  .001).
he proportion of patients discharged to an ICF increased
rom 23.1% in 1987 to 30.6% in 2004 (P  .001). Length
f stay decreased from 16.9 days in 1987 to 13.9 days in
004 (P  .001), but adjusted costs increased from $23,240
n 1987 to $38,659 in 2004 (P  .001). The 30-day mor-
ality rate was 12.1% in 1987 and 9.4% in 2004, although
he test of trend revealed no statistically significant differ-
nces over time (P  .24).
Patients undergoing operations were younger, had fewer
omorbid conditions, were more commonly men, and were
ore often Medicaid/charity care beneficiaries compared
ith patients not undergoing operations (Table 2). Pati
ndergoing operative therapy had better outcomes, with
ower 30-day mortality (5.4% vs 16.6%, P  .001), read-
ent, and outcomes
992 (n  1053) 1993-1998 (n  1407) 1999-2004 (n  1964)
.5  19.2 56.2  18.5 57.5  18.3
67.0 68.1 65.7
.9  1.8 1.1  1.9 1.1  1.9
15.1 15.4 18.5
44.4 51.6 55.4
10.9 11.4 10.3
4.7 4.1 4.6
19.5 24.8 30.3
.9  14.1 13.3  10.1 13.7  11.6
3  27,729 23,949  27,779 32,843  40,910gem
987-1
57
0
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TSission (3.0% vs 5.9%, P  .001), and discharge to an ICF
21.8% vs 30.1%, P  .001) rates compared with those of
atients undergoing nonoperative therapy. Interestingly, pa-
ients undergoing operations had longer hospitalizations and
reater hospital costs, but we could not assess the relative
ontribution of preintervention hospitalization time and
osts.
After adjusting for age, sex, comorbidity index, and
nsurance status, patients who had an operation were 58%
ess likely to die within 30 days (odds ratio, 0.42; 95% CI,
.32-0.56), 58% less likely to be readmitted (odds ratio,
.42; 95% CI, 0.31-0.57), and 17% less likely to be dis-
harged to an ICF (odds ratio, 0.83; 95% CI, 0.71-0.98).
atients undergoing operations had a 29% reduction in the
djusted risk of death over time (hazard ratio, 0.71; 95% CI,
.63-0.80). The greatest effect of an operation on survival
ppeared within the first year of follow-up, with an appar-
ntly similar risk of death beyond 1 year (Figure 2). Ov
9.6% of patients died (median survival, 13.2 years) within
he follow-up period.
iscussion
his study aimed to describe changes in the incidence of
leural space infections and the proportion of patients un-
ergoing operative therapy over time and to compare dif-
erences in patient characteristics and outcomes between
perative and nonoperative groups. We found an increasing
ncidence of pleural space infections and an increase in the
se of operative interventions. This study also found that
atients undergoing operations had more favorable out-
omes, even after adjusting for differential characteristics
hat might influence outcome, such as age, sex, burden of
ABLE 2. Patient characteristics and outcomes by man-
gement
Operative
(n  2281)
Nonoperative
(n  2143) P value
haracteristics
Age (y, mean  SD) 52.9  17.6 61.5  18.6 .001
Male sex (%) 70.1 62.7 .001
Comorbidity index
(mean  SD)
0.8  1.6 1.4  2.1 .001
Medicaid/charity (%) 19.4 13.8 .001
utcomes
30-d Mortality (%) 5.4 16.6 .001
Readmission (%) 3.0 5.9 .001
Discharge to ICF (%) 21.8 30.1 .001
LOS (d, mean  SD) 15.5  12.5 12.6  10.9 .001
Costs ($,
mean  SD)
32,112  36,060 22,318  32,174 .001
D, Standard deviation; ICF, institutional care facility; LOS, length of stay.omorbid conditions, and insurance status. T
The Journal of Thoracicl,
It is unclear why the incidence of pleural space infections
s increasing. Although older patients might be more likely
o have pleural space infections, the aging US population
lone might not account for this observation. For example,
e found that the mean age of patients with pleural space
nfection did not change significantly during the study
eriod. Alternatively, the growing number of patients
iving with chronic illness might explain this increase.
otential risk factors for pleural space infections include
ardiac disease,2 chronic lung disease,2 diabetes,2,10,11
besity, and tobacco and alcohol use.2,12 An increasing
omorbidity index over time confirms that patients with
leural space infections bear an increasing burden of
omorbid conditions. Finally, it is possible that the ob-
erved increase in incidence could be an artifact of in-
reased clinical awareness, identification, and coding of
his disease.
We found that the proportion of patients undergoing an
peration increased over time. One explanation for this
rowth is an increase in access to and use of better imaging
echnology. Ultrasonography and computed tomography are
ell suited to detect loculations and pleural and extrapleural
at enhancement,13 findings that might influence a surgeon
ecision to operate. A second possibility is an increase in
ccess to well-trained thoracic surgeons and their influence
n the community to consider earlier and more aggressive
urgical intervention. The introduction of VATS in the
990s as a less-invasive and apparently effective approach
or many thoracic operations might also have contributed to
he increasing proportion of operations being performed. In
different studies of patients with pleural space infec-
ions,14,15 those undergoing VATS had a shorter duration
reoperative symptoms than those undergoing thoracotomy.
igure 2. Kaplan–Meier plots of cumulative case fatality rates by
anagement.his observation is consistent with the hypothesis that the
and Cardiovascular Surgery ● Volume 133, Number 2 349
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G
TSvailability of VATS has lowered the threshold to operate,
ossibly because of greater patient and physician accep-
ance of this less-invasive option.
Compared with patients who did not undergo an opera-
ion, patients who did undergo operative management had
arkedly different baseline characteristics and outcomes.
he observation that patients undergoing operations were
ounger and apparently healthier (although also more likely
ale and economically disadvantaged) supports the hypoth-
sis that patient characteristics influence treatment selec-
ion. It seems likely that physicians managing patients
ho were older and with higher comorbidity were more
esitant to refer for operative intervention, that thoracic
urgeons were less likely to advise surgical intervention,
r both. After adjustment, patients undergoing operations
till had a lower risk of early mortality, readmission, and
ischarge to an ICF. This finding is consistent with the
ypothesis that operative drainage of the pleural space is
ore efficacious than nonoperative drainage, but this
tudy could not completely distinguish the effect of other
mportant but unmeasured patient characteristics on these
utcomes.
We found a higher risk of death for both patients undergo-
ng operations (5.4%) and patients not undergoing operations
16.6%) than previous estimates derived from aggregate pub-
ished data (1.9%-4.8% and 4.3%-10.3%, respectively).1 Pub-
ication and selection bias might account for lower published
isks of death for the 2 management strategies. Another
ossible explanation is that care in the community at large,
specially nonoperative management, is less effective com-
ared with care in institutions that publish research on
leural space infections.
Our investigation has several limitations. Administrative
ata sets do not contain sufficient clinical information to ade-
uately adjust for potential confounding based on the severity
f infection or underlying comorbidity. Additionally, adminis-
rative data do not contain information on the timing of pro-
edures, and therefore a distinction between primary and sec-
ndary procedures was not possible. ICD-9 procedure codes
o not exist for therapeutic VATS drainage/decortication or
mage-directed catheters, and thus direct evaluation of the
ffect of new technology was not possible. We aimed to
inimize misclassification of patients included in our co-
ort by requiring all patients to have an associated ICD-9
rocedure code, given that some form of drainage of pleural
pace infection is the standard of care. Although diagnostic
odes are susceptible to miscoding or undercoding, proce-
ure codes have a higher yield because procedures are
iscrete billing events. This approach, however, might have
xcluded patients who truly had pleural space infections that
ere never drained. This bias would likely underestimate
he true incidence of pleural space infection. We also ex-
luded patients who had ICD-9 procedure codes for thoracic
50 The Journal of Thoracic and Cardiovascular Surgery ● Febrperations used to treat conditions other than pleural space
nfection. We believe these patients likely represent a group
hat had pleural space infection as a consequence of a
horacic operation and accordingly have a different risk
rofile for adverse outcomes compared with the population
hat typically acquires pleural space infection as a result of
neumonia. Concerned that attempts to conservatively de-
ne our cohort might have significantly altered the results,
e performed several post-hoc analyses of temporal trends
nd comparisons across treatment groups, varying the def-
nition of pleural space infection to include patients we had
riginally excluded. Although absolute estimates were
lightly different, neither trends nor tests of significance
ere different than those reported.
In summary, the incidence of pleural space infection and
he proportion of patients undergoing operative manage-
ent are increasing. Patients who undergo operative ther-
py have a lower risk of death, readmission, and being
ischarged to an ICF, although these patients are also typ-
cally younger and with less comorbid illness. Thoracic
urgeons can use these findings to (1) better inform their
atients that an 18-year statewide experience confirms that
perative management is a relatively safe and effective
rocedure for selected patients with pleural space infections
nd (2) better educate their medical colleagues about the
mportance of early referral for thoracic surgical consulta-
ion. Future investigations should aim to describe the pro-
ortion of patients undergoing primary operative therapy,
etter identify potential confounders, measure quality of life
nd functional status, and evaluate the cost-effectiveness of
ompeting therapies.
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Appendix E1
Lung resection (32.0, 32.09, 32.1, 32.21, 32.22, 32.29, 32.3, 32.4,
32.5, 32.6, 32.9, 33.0, 33.1, 33.25, 33.26, 33.28), destruction of
phrenic nerve (33.31), artificial pneumothorax for collapse of lung
(33.32, 33.39), thoracoplasty (33.34), suture of laceration of the
bronchus (33.41), closure of laceration of lung (33.43), other repair
and plastic operation on bronchus (33.48), lung transplantation
(33.50, 33.51, 33.52, 33.6), other repair and plastic operation on
lung (33.49), ligation of bronchus (33.92), puncture of lung
(33.93), other operation of lung or bronchus (33.98, 33.99), inci-
sion of mediastinum (34.1), pleural biopsy (34.24), open biopsy of
mediastinum (34.26), biopsy of diaphragm (34.27), pleurodesis
(34.6, 34.92), other repair of chest wall (34.79), excision of lesion
or tissue of diaphragm (34.81), suture of laceration of diaphragm
(34.82), closure of fistula of diaphragm (34.83), other repair of
diaphragm (34.84), implantation of diaphragmatic pacemaker
(34.85), other operations on diaphragm (34.89), repair of pleura
(34.93), other operations on thorax (34.99), closed heart valvot-
omy (35.00-35.04), open heart valvuloplasty without replacement
(35.10-35.14), replacement of heart valve (35.20-35.28), opera-
tions on structures adjacent to heart valves (35.31-35.35, 35.39),
creation of septal defect in heart (35.42), repair of atrial and
ventricular septa with prosthesis (35.50, 35.51, 35.54), repair of
atrial and ventricular septa with tissue graft (35.60-35.63), other
and unspecified repair of atrial and ventricular septa (35.70-35.73),
total repair of certain congenital cardiac anomalies (35.80-35.84),
other operations on valves and septa of heart (35.90-35.95, 35.98,
35.99), operations on vessels of heart (36.03), bypass anastomosis
for heart revascularization (36.10-17, 36.19), heart revasculariza-
tion by arterial implant (36.20), other heart revascularization
(36.31, 36.32, 36.39), other operations on vessels of heart (36.91,
36.99), cardiotomy and pericardiotomy (37.10-37.12), biopsy of
pericardium or heart (37.24, 37.25), pericardiectomy and excision
of lesion of heart (37.31-37.35), repair of heart and pericardium
(37.41, 37.49), heart replacement procedures (37.51-37.54), im-
plantation of heart and circulatory assist system (37.62-37.68),
insertion of left atrial appendage device (37.90), incision of esoph-
ageal web (42.01), other incision of esophagus (42.09), esopha-
gostomy not otherwise specified (42.1), exteriorization of esoph-
ageal pouch (42.12), other external fistulization of esophagus
(42.19), operative esophagoscopy by incision (42.21), open biopsy
of esophagus (42.25), local excision of esophageal diverticulum
(42.31), local excision of other lesion or tissue of esophagus
(42.32), other destruction of lesion or tissue of esophagus (43.39),
esophagectomy (42.40-42.42), intrathoracic anastomosis of esoph-
agus (42.50-42.56, 42.58, 42.59), antesternal anastomosis of
esophagus (42.60-42.66, 42.68, 42.69), esophagomyotomy (42.7),
insertion of permanent tube into esophagus (42.81), other repair of
esophagus (42.82-42.87, 42.89), and ligation of esophageal varices
(42.91).
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